Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John M. Evans currently holds 1,047,205 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John M. Evans has been a net seller of BEAM stock. They have purchased $0 and sold $32.6M worth of shares.
John M. Evans's most recent insider trade was on Apr 1, 2026, when they sold 30,078 shares at $24.58 per share.
John M. Evans serves as Executive at Beam Therapeutics Inc. (BEAM). They have executed 122 insider transactions totaling $32.6M over their tenure at the company.
John M. Evans holds the position of Executive at Beam Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
John M. Evans has shown a selling trading pattern, with $0 in total purchases and $32.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John M. Evans was on Jan 31, 2024, when they purchased $3.8M worth of BEAM shares. This transaction involved 155,000 shares at $24.40 per share.
John M. Evans currently owns 1,047,205 shares of Beam Therapeutics Inc. (BEAM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John M. Evans's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John M. Evans has 122 Form 4 filings on record as an insider at Beam Therapeutics Inc..
Set alerts for John M. Evans and 40,000+ other insiders.